FeNO Breath Analyzer Market Research: at a CAGR of 12.8% during the forecast period
クレジット
FeNO Breath Analyzer
FeNO Breath Analyzer Market Research: at a CAGR of 12.8% during the forecast period
The global market for FeNO Breath Analyzer was estimated to be worth US$ 125.69 million in 2025 and is projected to reach US$ 285.79 million by 2032, growing at a CAGR of 12.80% from 2026 to 2032.
Global Market Research Publisher QYResearch (QY Research) announces the release of its latest report “FeNO Breath Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on 2025 market situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global FeNO Breath Analyzer market, including market size, market share, market volume, demand, industry development status, and forecasts for the next few years.
The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5512355/feno-breath-analyzer
FeNO Breath Analyzer Market Summary
1. Product Overview
The FeNO breath analyzer is a specialized medical device used to quantitatively measure the fraction of exhaled nitric oxide, assessing the level of eosinophilic inflammation in the airways and providing objective biomarkers for the diagnosis and treatment of chronic respiratory diseases such as asthma. The device works by having the individual exhale into it, after which the exhaled breath is analyzed to determine the concentration of nitric oxide present. Results are typically available immediately or within a short period, allowing for real-time assessment and adjustment of treatment plans. It can be performed in both adults and children, making it a useful tool in managing asthma in pediatric patients as well.
2. Market Size and Growth
The global FeNO Breath Analyzer market is projected to reach USD 286 million by 2032, growing at a CAGR of 12.8% during the forecast period.
3. Leading Players
Key manufacturers in the global FeNO Breath Analyzer market include NIOX Group (Circassia AB), CAIRE (Niterra), Bosch Healthcare Solutions, Bedfont Scientific, and ECO PHYSICS AG. In 2025, the global top five players accounted for approximately 86% of revenue.
4. Market Segmentation by Product Type
Desktop FeNO Breath Analyzers
1.1 Typically deployed in respiratory and pediatric departments of tertiary hospitals, as well as in research institutions.
1.2 Positioned as high-performance airway inflammation detection platforms.
1.3 Represented by models such as the ANALYZER CLD 88 sp from Switzerland's ECO PHYSICS.
1.4 These devices employ chemiluminescence nitric oxide analysis technology.
1.5 They can continuously and synchronously display nitric oxide concentration, flow rate, and volume during the breathing process.
Handheld FeNO Breath Analyzers
2.1 Designed around point-of-care testing and convenient follow-up.
2.2 Target settings such as respiratory clinics, allergy specialists, and home use.
2.3 The NObreath from the UK's Bedfont Scientific is described as a nitric oxide device for asthma diagnosis and management.
2.4 It emphasizes completely non-invasive and simple operation suitable for both adult and pediatric patients.
Segment Share
3.1 Desktop is currently the largest segment, holding a share of 83.4%.
5. Market Segmentation by Application
Testing Methods
1.1 FeNO is available in both online and offline testing methods.
1.2 Both methods have the same requirements for pressure and flow rate, requiring an expiratory pressure of 5 cmH2O to close the soft palate and avoid upper airway effects.
1.3 The expiratory flow rate is 50 mL/s, maintained within a range of ±10%.
1.4 Exhalation time is at least 4 seconds for children aged 12 years and under in child mode.
1.5 The offline method can be used in children aged 3 years and above if they cannot cooperate with the online method.
1.6 The online method requires one breath exhalation to be completed for at least 6 seconds for adults over 12 years in adult mode.
1.7 The offline method is a multi-breath measurement with no requirement for exhalation time, and adults can exhale multiple times until sampling is complete.
Application Share
2.1 Adults currently represent the largest segment, holding a share of 64.6%.
6. Market Trends
Evolution of Product Form
1.1 The industry is evolving from early desktop chemiluminescence analyzers to a landscape dominated by portable, handheld, and point-of-care testing devices.
1.2 The NIOX VERO, launched by the UK-based NIOX Group, is positioned by the company as the gold standard in FeNO technology and supports bedside testing in primary care clinics and specialized centers.
1.3 Bedfont's NObreath is also a handheld FeNO device, described as widely used in general practice and respiratory clinics across the UK.
Expansion Beyond Specialist Settings
2.1 FeNO is rapidly expanding from a specialist tool to primary care, pediatric clinics, and community management.
2.2 NIOX and Bedfont consistently publish guideline interpretations, online courses, and remote training content on their official websites and educational platforms.
2.3 These efforts enhance physicians' understanding of FeNO's role in identifying asthma phenotypes and stratifying biologic therapy.
7. Market Challenges
Clinical Limitations and Standardization Gaps
1.1 For certain populations, FeNO is not recommended as a routine tool for predicting future asthma.
1.2 Guidelines repeatedly emphasize that FeNO should not be used in isolation for making management decisions.
1.3 A Chinese multicenter pediatric study indicated that, compared to the cutoff values recommended by the American ATS, local reference intervals show differences in efficacy assessment.
Cost and Maintenance Burden
2.1 The NIOX VERO utilizes a pre-calibrated sensor, which requires periodic replacement of the sensor module.
2.2 The NObreath device relies on disposable mouthpieces and regular maintenance.
2.3 For primary care institutions with limited resources, the combined costs of equipment procurement, consumables, and training can slow the pace of adoption.
8. Market Drivers
Authoritative Clinical Guidelines
1.1 The ATS guidelines systematically summarize the application scenarios of FeNO in airway inflammation assessment and inhaled corticosteroid treatment monitoring.
1.2 These authoritative documents collectively reinforce the status of FeNO as a biomarker for type II inflammation.
1.3 This provides a medical basis for device deployment worldwide.
Demand for Refined Asthma Management and Personalized Medication
2.1 This demand has created significant commercial opportunities.
2.2 Bedfont's collaboration with the American Allergy Partners network has led to the deployment of NObreath devices in over a hundred allergy and asthma clinics as part of their standard workflow.
2.3 This optimizes patient stratification and management.
Rise of Domestic Manufacturers and Digital Health Integration
3.1 Chinese domestic manufacturers, such as Sunvou Medical Electronics and e-LinkCare Meditech, have launched locally registered FeNO analyzers targeting respiratory specialty departments and health examination institutions.
3.2 With advancements in portable design, battery power, and Bluetooth connectivity, FeNO testing is expanding into home monitoring, remote follow-up, and digital asthma management platforms.
3.3 This opens up opportunities for collaboration between device manufacturers and digital health companies.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The FeNO Breath Analyzer market is segmented as below:
By Company
NIOX Group (Circassia AB)
CAIRE (Niterra)
Bosch Healthcare Solutions
Bedfont Scientific
ECO PHYSICS AG
Sunvou Medical Electronics
e-LinkCare Meditech
Hefei Micro Valley Medical
Segment by Type
Desktop
Handheld
Segment by Application
Children
Adults
Each chapter of the report provides detailed information for readers to further understand the FeNO Breath Analyzer market:
Chapter 1: Introduces the report scope of the FeNO Breath Analyzer report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of FeNO Breath Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various FeNO Breath Analyzer market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of FeNO Breath Analyzer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of FeNO Breath Analyzer in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth FeNO Breath Analyzer competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides FeNO Breath Analyzer comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides FeNO Breath Analyzer market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global FeNO Breath Analyzer Market Outlook, In‑Depth Analysis & Forecast to 2032
Global FeNO Breath Analyzer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global FeNO Breath Analyzer Market Research Report 2026
Global FeNO Breath Analyzer Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032
Global Handheld FeNO Breath Analyzers Market Research Report 2026
Global Handheld FeNO Breath Analyzers Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Handheld FeNO Breath Analyzers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
To contact us and get this report: https://www.qyresearch.com/contact-us
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
クレジット
FeNO Breath Analyzer
あなたのforiioを無料で作成
FeNO Breath Analyzer Market Research: at a CAGR of 12.8% during the forecast period
The global market for FeNO Breath Analyzer was estimated to be worth US$ 125.69 million in 2025 and is projected to reach US$ 285.79 million by 2032, growing at a CAGR of 12.80% from 2026 to 2032.
Global Market Research Publisher QYResearch (QY Research) announces the release of its latest report “FeNO Breath Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on 2025 market situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global FeNO Breath Analyzer market, including market size, market share, market volume, demand, industry development status, and forecasts for the next few years.
The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5512355/feno-breath-analyzer
FeNO Breath Analyzer Market Summary
1. Product Overview
The FeNO breath analyzer is a specialized medical device used to quantitatively measure the fraction of exhaled nitric oxide, assessing the level of eosinophilic inflammation in the airways and providing objective biomarkers for the diagnosis and treatment of chronic respiratory diseases such as asthma. The device works by having the individual exhale into it, after which the exhaled breath is analyzed to determine the concentration of nitric oxide present. Results are typically available immediately or within a short period, allowing for real-time assessment and adjustment of treatment plans. It can be performed in both adults and children, making it a useful tool in managing asthma in pediatric patients as well.
2. Market Size and Growth
The global FeNO Breath Analyzer market is projected to reach USD 286 million by 2032, growing at a CAGR of 12.8% during the forecast period.
3. Leading Players
Key manufacturers in the global FeNO Breath Analyzer market include NIOX Group (Circassia AB), CAIRE (Niterra), Bosch Healthcare Solutions, Bedfont Scientific, and ECO PHYSICS AG. In 2025, the global top five players accounted for approximately 86% of revenue.
4. Market Segmentation by Product Type
Desktop FeNO Breath Analyzers
1.1 Typically deployed in respiratory and pediatric departments of tertiary hospitals, as well as in research institutions.
1.2 Positioned as high-performance airway inflammation detection platforms.
1.3 Represented by models such as the ANALYZER CLD 88 sp from Switzerland's ECO PHYSICS.
1.4 These devices employ chemiluminescence nitric oxide analysis technology.
1.5 They can continuously and synchronously display nitric oxide concentration, flow rate, and volume during the breathing process.
Handheld FeNO Breath Analyzers
2.1 Designed around point-of-care testing and convenient follow-up.
2.2 Target settings such as respiratory clinics, allergy specialists, and home use.
2.3 The NObreath from the UK's Bedfont Scientific is described as a nitric oxide device for asthma diagnosis and management.
2.4 It emphasizes completely non-invasive and simple operation suitable for both adult and pediatric patients.
Segment Share
3.1 Desktop is currently the largest segment, holding a share of 83.4%.
5. Market Segmentation by Application
Testing Methods
1.1 FeNO is available in both online and offline testing methods.
1.2 Both methods have the same requirements for pressure and flow rate, requiring an expiratory pressure of 5 cmH2O to close the soft palate and avoid upper airway effects.
1.3 The expiratory flow rate is 50 mL/s, maintained within a range of ±10%.
1.4 Exhalation time is at least 4 seconds for children aged 12 years and under in child mode.
1.5 The offline method can be used in children aged 3 years and above if they cannot cooperate with the online method.
1.6 The online method requires one breath exhalation to be completed for at least 6 seconds for adults over 12 years in adult mode.
1.7 The offline method is a multi-breath measurement with no requirement for exhalation time, and adults can exhale multiple times until sampling is complete.
Application Share
2.1 Adults currently represent the largest segment, holding a share of 64.6%.
6. Market Trends
Evolution of Product Form
1.1 The industry is evolving from early desktop chemiluminescence analyzers to a landscape dominated by portable, handheld, and point-of-care testing devices.
1.2 The NIOX VERO, launched by the UK-based NIOX Group, is positioned by the company as the gold standard in FeNO technology and supports bedside testing in primary care clinics and specialized centers.
1.3 Bedfont's NObreath is also a handheld FeNO device, described as widely used in general practice and respiratory clinics across the UK.
Expansion Beyond Specialist Settings
2.1 FeNO is rapidly expanding from a specialist tool to primary care, pediatric clinics, and community management.
2.2 NIOX and Bedfont consistently publish guideline interpretations, online courses, and remote training content on their official websites and educational platforms.
2.3 These efforts enhance physicians' understanding of FeNO's role in identifying asthma phenotypes and stratifying biologic therapy.
7. Market Challenges
Clinical Limitations and Standardization Gaps
1.1 For certain populations, FeNO is not recommended as a routine tool for predicting future asthma.
1.2 Guidelines repeatedly emphasize that FeNO should not be used in isolation for making management decisions.
1.3 A Chinese multicenter pediatric study indicated that, compared to the cutoff values recommended by the American ATS, local reference intervals show differences in efficacy assessment.
Cost and Maintenance Burden
2.1 The NIOX VERO utilizes a pre-calibrated sensor, which requires periodic replacement of the sensor module.
2.2 The NObreath device relies on disposable mouthpieces and regular maintenance.
2.3 For primary care institutions with limited resources, the combined costs of equipment procurement, consumables, and training can slow the pace of adoption.
8. Market Drivers
Authoritative Clinical Guidelines
1.1 The ATS guidelines systematically summarize the application scenarios of FeNO in airway inflammation assessment and inhaled corticosteroid treatment monitoring.
1.2 These authoritative documents collectively reinforce the status of FeNO as a biomarker for type II inflammation.
1.3 This provides a medical basis for device deployment worldwide.
Demand for Refined Asthma Management and Personalized Medication
2.1 This demand has created significant commercial opportunities.
2.2 Bedfont's collaboration with the American Allergy Partners network has led to the deployment of NObreath devices in over a hundred allergy and asthma clinics as part of their standard workflow.
2.3 This optimizes patient stratification and management.
Rise of Domestic Manufacturers and Digital Health Integration
3.1 Chinese domestic manufacturers, such as Sunvou Medical Electronics and e-LinkCare Meditech, have launched locally registered FeNO analyzers targeting respiratory specialty departments and health examination institutions.
3.2 With advancements in portable design, battery power, and Bluetooth connectivity, FeNO testing is expanding into home monitoring, remote follow-up, and digital asthma management platforms.
3.3 This opens up opportunities for collaboration between device manufacturers and digital health companies.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The FeNO Breath Analyzer market is segmented as below:
By Company
NIOX Group (Circassia AB)
CAIRE (Niterra)
Bosch Healthcare Solutions
Bedfont Scientific
ECO PHYSICS AG
Sunvou Medical Electronics
e-LinkCare Meditech
Hefei Micro Valley Medical
Segment by Type
Desktop
Handheld
Segment by Application
Children
Adults
Each chapter of the report provides detailed information for readers to further understand the FeNO Breath Analyzer market:
Chapter 1: Introduces the report scope of the FeNO Breath Analyzer report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of FeNO Breath Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various FeNO Breath Analyzer market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of FeNO Breath Analyzer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of FeNO Breath Analyzer in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth FeNO Breath Analyzer competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides FeNO Breath Analyzer comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides FeNO Breath Analyzer market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global FeNO Breath Analyzer Market Outlook, In‑Depth Analysis & Forecast to 2032
Global FeNO Breath Analyzer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global FeNO Breath Analyzer Market Research Report 2026
Global FeNO Breath Analyzer Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032
Global Handheld FeNO Breath Analyzers Market Research Report 2026
Global Handheld FeNO Breath Analyzers Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Handheld FeNO Breath Analyzers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
To contact us and get this report: https://www.qyresearch.com/contact-us
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
クレジット
FeNO Breath Analyzer